By: DSM Pharma Solutions Editors
The ‘Products with Purpose’ campaign reflects dsm-firmenich’s evolved strategic direction as a purpose-led partner in the global pharmaceutical market. It brought the company’s broad offering to life through a range of distinct and engaging concepts that express how dsm-firmenich sees the individual impact of every therapeutic innovation it helps create. By drawing attention to purpose, the campaign demonstrates the company’s unique understanding of the humanity of the end patient and how the development of, agile and safe therapies can improve patients’ quality of life. Where others may see each product as merely an item on a shelf, dsm-firmenich sees the patient behind its customers’ solutions.
“We are so excited that our ‘Products with Purpose’ campaign has been recognized for its creativity and branding. It is a big achievement for a B2B company to win these types of awards and a remarkable honor to follow in the footsteps of hugely successful brands and past winners, like Adobe,” says Outi Armstrong, Director Global Marketing Communications, dsm-firmenich Human Nutrition and Health. “Although I’m exceptionally proud of these great achievements, I’d like to put the spotlight on the real winners – our fantastic team at dsm-firmenich – who has brought our new positioning to life through a truly imaginative and inspirational campaign with our partner agency Fingerpaint. It really is an excellent representation of how we take a customer-first approach to champion humanity and help unlock new therapies that will keep the world’s growing population healthy. The results of this journey speak for themselves – powerful creative concepts that communicate our strategic platform and expertise across every vertical in an instantly recognizable and memorable way.”
The ‘Products with Purpose’ creative was rolled out across multiple touchpoints, including trade press, digital advertising and social media, inviting customers to learn more about how partnering with dsm-firmenich can ignite growth through co-innovation. In just six months, the largely digital campaign has achieved more than 15 million impressions, signifying the success of the initiative.
In addition to winning the ‘Best Graphics’ award at the Shorty Awards and the silver award for ‘Brand Purpose’ at the B2 Awards, the campaign also saw dsm-firmenich receive a finalist distinction in the Shorty Awards ‘Best in Brand Redesign’ and ‘Best in Fitness, Health, and Wellness’ categories, as well as a nominee distinction in ‘Best Art Direction’, ‘Best Global Campaign’, ‘Best in Business to Business’, and ‘Best Integrated Campaign’.
dsm-firmenich has built a robust legacy in the API market. However, its perception solely as an ingredient provider no longer reflects the reality of dsm-firmenich as a business. The company brings expertise and innovation to co-develop new over-the-counter products and prescription medicines in the ever-changing and competitive marketplace. It also realizes the importance of post-launch success; lifecycle management support programs ensure the continued growth and evolution of these products across their entire lifecycle. In addition, dsm-firmenich’s 400-strong R&D team, portfolio of patents, global network of regulatory specialists, and key scientific, academic, and manufacturing partnerships provide the foundational capabilities for timely and effective product co-innovation. This makes dsm-firmenich an ideal partner to address emerging therapeutic areas benefiting global patient health while helping our customers achieve long-term growth.
Want to learn more about how purpose drives everything at dsm-firmenich? Find out more at PartnerwithDSM.com.
26 May 2021
3 min read
Stay up-to-date on the latest science, events and market trends